ArticlemAbs

Discovery and development of ANV419, an IL-2/anti-IL-2 antibody fusion protein with potent CD8+ T and natural killer cell-stimulating capacity for cancer immunotherapy.

Patrizia Murer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.